Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Not Receiving ESAs With Anemia Associated With Chronic Kidney Disease in Japan

Clinical trial NCT03461146 · COMPLETED

Trial details

NCT number

NCT03461146

Sponsor

Tanabe Pharma Corporation

Status

COMPLETED

Phase

Phase 3

Study type

INTERVENTIONAL

Start date

2018-03-05

Primary completion

2018-12-03

Enrollment

24

View on ClinicalTrials.gov